Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

(2017) John P Neoptolemos et al.   LANCET

The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After

(2017) Claudio Bassi et al.   SURGERY

Pancreatic Adenocarcinoma, Version 2.2014

(2017) Margaret A. Tempero et al.   Journal of the National Comprehensive Cancer Network

Modified Appleby Procedure for Pancreatic Adenocarcinoma: Does Improved Neoadjuvant Therapy Warrant Such an Aggressive Approach?

(2016) Niek A. Peters et al.   ANNALS OF SURGICAL ONCOLOGY

Distal Pancreatectomy with en Bloc Celiac Axis Resection (Modified Appleby Procedure) for Locally Advanced Pancreatic Body Cancer: A Single-Center Review of 80 Consecutive Patients

(2016) Toru Nakamura et al.   ANNALS OF SURGICAL ONCOLOGY

Systematic review of outcomes after distal pancreatectomy with coeliac axis resection for locally advanced pancreatic cancer

(2016) S. Klompmaker et al.   BRITISH JOURNAL OF SURGERY

FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis

(2016) Mustafa Suker et al.   LANCET ONCOLOGY

Surgical Indications of Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Body/Tail Cancer

(2016) Teiichi Sugiura et al.   WORLD JOURNAL OF SURGERY

Robotic and open distal pancreatectomy with celiac axis resection for locally advanced pancreatic body tumors: a single institutional assessment of perioperative outcomes and survival

(2016) Lee M. Ocuin et al.   HPB

Modified Appleby procedure for borderline resectable/locally advanced distal pancreatic adenocarcinoma: A major procedure for selected patients

(2016) M. Cesaretti et al.   Journal of Visceral Surgery

FOLFIRINOX in Locally Advanced and Metastatic Pancreatic Cancer: A Single Centre Cohort Study

(2016) SJ Rombouts et al.   Journal of Cancer

Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer

(2015) Cristina R. Ferrone et al.   ANNALS OF SURGERY

FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma

(2015) Eran Sadot et al.   ANNALS OF SURGICAL ONCOLOGY

Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)

(2014) Maximilian Bockhorn et al.   SURGERY

Preservation of the Left Gastric Artery on the Basis of Anatomical Features in Patients Undergoing Distal Pancreatectomy with Celiac Axis En-bloc Resection (DP-CAR)

(2014) Ken-ichi Okada et al.   WORLD JOURNAL OF SURGERY

Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design

(2013) Matthew H. G. Katz et al.   ANNALS OF SURGICAL ONCOLOGY

Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2012) T. Seufferlein et al.   ANNALS OF ONCOLOGY

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

(2011) Thierry Conroy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement

(2009) Mark P. Callery et al.   ANNALS OF SURGICAL ONCOLOGY